Holen Sie sich die Stockscreener-App
1.155
1.28%
-0.015
Schlusskurs vom Vortag:
$1.17
Offen:
$1.16
24-Stunden-Volumen:
381.28K
Relative Volume:
0.38
Marktkapitalisierung:
$140.35M
Einnahmen:
Nettoeinkommen (Verlust:
$-26.33M
KGV:
-4.0899
EPS:
-0.2824
Netto-Cashflow:
$-17.65M
1W Leistung:
+0.43%
1M Leistung:
-38.89%
6M Leistung:
-23.51%
1J Leistung:
-2.94%
1-Tages-Spanne:
$1.15
$1.19
1-Wochen-Bereich:
$1.08
$1.19
52-Wochen-Spanne:
$0.88
$2.34
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
Compare CRDL vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.155 | 140.35M | 0 | -26.33M | -17.65M | -0.2824 |
TAK
Takeda Pharmaceutical Co Adr
|
20.38 | 65.09B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
40.05 | 46.71B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.37 | 45.58B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
81.99 | 33.88B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
583.28 | 25.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-26 | Eingeleitet | B. Riley Securities | Buy |
| 2025-06-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-06-26 | Eingeleitet | ROTH MKM | Buy |
| 2024-04-22 | Eingeleitet | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten
Apollomics Inc. Class A (APLM) Stock Price & News - Syfe
Cardiol Therapeutics (TSX:CRDL): Why Is The MAVERIC Trial Getting Bigger? - Kalkine Media
Medical Marijuana Clinical Trial Landscape Expands as 60+ Leading Companies Accelerate Drug Development | DelveInsight - GlobeNewswire Inc.
HLS Therapeutics (TSX:HLS) Stock Falls 7.38% Despite Expanded Share Buyback - kalkine.ca
Why Custom Health Holdings Inc. (CHLT) is buying pharmacies and dispensing technology after its TSX debut - kalkine.ca
Diluted net income available to common stockholders of Cardiol Therapeutics Inc. Class A – HAN:CT9 - TradingView
Calidi Biotherapeutics (NYSEAMERICAN:CLDI) Races to Fix an Equity Shortfall Before Delisting - kalkine.ca
Cardiol Therapeutics Inc. (CRDL.TO) Stock Price, News, Quote & History - Yahoo! Finance Canada
ME Therapeutics Holdings (CN:METX:CNX) Stock Rebounds 14.29%: In Vivo CAR-T and mRNA STING Program Pacing, Micro-Cap Liquidity Dynamics, and Preclinical Biotech Re-Rating Examined - kalkine.ca
How TelyRx (TSX:TELY) Grew Revenue 143% in a Year - kalkine.ca
Cardiol Therapeutics Inc. (CRDL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tejara Capital Holds 5.3% Stake in Cardiol Therapeutics (NASDAQ: CRDL), Owning 6.38 Million Shares - Kalkine Media
Fund manager reports 6.4M Cardiol Therapeutics (NASDAQ: CRDL) shares - Stock Titan
German investor discloses stake in Werewolf Therapeutics (NASDAQ: HOWL) - Stock Titan
HLS Therapeutics Inc. Stock Slips 0.99%: Cardiovascular Market Adoption Friction, Specialty Pharma Valuation Sensitivity, and Revenue Transition Weigh on Sentiment - kalkine.ca
TSXV:GSD Edges Higher as Devonian Targets NYSE American Listing and Advances Thykamine Development - kalkine.ca
[Form 4] New Fortress Energy Inc. Insider Trading Activity - Stock Titan
Nelnet (NYSE: NNI) director’s stake climbs to 31,953 shares - Stock Titan
Cardiol Therapeutics (Nasdaq: CRDL) opens path to raise cash for heart drug trials - Stock Titan
How Jolt Health (CN:JOLT.X) Could Bring Fresh Energy to Canada's Healthcare Micro-Caps - kalkine.ca
Why Adaptogenics Health (CN:ADPT) Could Ride Growing Interest in Wellness Companies - kalkine.ca
Alta Partners reports 2.1M Envoy Medical (COCH) shares - stocktitan.net
Cardiol Therapeutics: Q1 2027 Readout Will Be Make-Or-Break For MAVERIC (NASDAQ:CRDL) - Seeking Alpha
Cardiol Therapeutics (TSX:CRDL) Slides 12.34% as Volatility Returns and Investors Reassess the Clinical-Stage Risk - kalkine.ca
Cardiol Therapeutics Stock Faces Renewed Pressure as Biotech Risk and Clinical Uncertainty Weigh on Sentiment - kalkine.ca
Cardiol Therapeutics (CRDL) sets terms with new manufacturing and drug ingredient partners - Stock Titan
Cardiol Therapeutics files $150 million shelf prospectus By Investing.com - Investing.com Nigeria
CRDL: Cardiol Therapeutics IncOrdinary SharesClass A Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus - TradingView
Cardiol Therapeutics files $150 million shelf prospectus - Investing.com
Cardiol Therapeutics files $150 million shelf prospectus By Investing.com - Investing.com Canada
Cardiol Therapeutics files $150 million shelf prospectus - Investing.com India
New 25‑month shelf lets Cardiol Therapeutics (CRDL) line up future financing - Stock Titan
Cardiol Therapeutics files US$150M base shelf prospectus - TradingView
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission - PR Newswire
Cardiol Therapeutics Inc. (NASDAQ: CRDL) to Host Fireside Chat on September 14 at H.C. Wainwright Investment Conference - Kalkine Media
Cardiol Therapeutics (NASDAQ: CRDL) lines up new shelf to fund drug trials - Stock Titan
Cardiol Therapeutics Files For Mixed Shelf Offering Of Up To $150 Mln - TradingView
Cardiol Therapeutics Inc. Class A (TSX:CRDL) Gains Momentum as Cardiovascular Drug Pipeline Progress Strengthens Investor Optimism - kalkine.ca
US$150M filing does not mean a sale is happening. Cardiol may offer securities later. - Stock Titan
Cardiol Therapeutics files $150 million shelf prospectus By Investing.com - Investing.com UK
Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission - PR Newswire Canada
Cardiol Therapeutics (TSX:CRDL) Healthcare Stock Latest Update - Kalkine Media
Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail
Heart-drug developer Cardiol Therapeutics (CRDL) heads to a major New York investor conference - Stock Titan
Cardiol Therapeutics will join a heart-disease drug chat in New York Sept. 14 - Stock Titan
Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference - PR Newswire
ADAG Stock Price, Quote & News - Syfe
Global-E Online (GLBE) officer to sell 12,500 shares in 2026 - Stock Titan
Cardiol Therapeutics Inc. (TSX:CRDL) Climbs 10.18% as Phase III Catalyst and CardiolRx Momentum Strengthen Investor Optimism - kalkine.ca
Finanzdaten der Cardiol Therapeutics Inc-Aktie (CRDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.00%
6.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):